Alice I. Nichols, PhD
- 3Articles
- 12.1KReads
- 2010–2015Active
- 13Collaborators
- 200Citations
About
Alice I. Nichols, PhD, has published extensively on the pharmacokinetics and genetics of antidepressant treatment in major depressive disorder and related psychiatric conditions. Her work includes studies on cytochrome P450 2D6 phenoconversion and its implications for personalized medicine, as well as analyses of drug-drug interactions using desvenlafaxine as a model. Nichols's research also addresses the genetic factors influencing antidepressant efficacy, particularly in the context of venlafaxine treatment.
Publications
How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example
March 19, 2015
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
